Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Heart device registry enrolls 5,000 patients to monitor Real-World outcomes

NCT ID NCT04460209

Knowledge-focused Sponsor: Abbott Medical Devices Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed registry study followed over 5,000 people with heart rhythm disorders who received Abbott devices during standard procedures. The goal was to collect real-world data on safety and how well the devices work. No new treatments were tested; instead, the study observed outcomes from routine care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

5,003 people

The number who actually took part.

Started

Jun 2020

Finished

Jan 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Male and female subjects of all ages who underwent an electrophysiology (EP) imaging (diagnostic procedure) and/or ablation procedure that used at least one Abbott device covered by this Registry.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Subject underwent an electrophysiology imaging (diagnostic procedure) and/or ablation procedure that used one or more Abbott devices covered by this Registry. * Subject is willing and able to comply with the site's standard of care follow-up schedule. Exclusion Criteria: * Subject is currently participating in another clinical investigation that may confound the results of this Registry.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiac rhythm disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Arrhythmias, Cardiac cardiac rhythm disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiac rhythm disorder

Contacts and locations

Locations

  • A. ö. Krankenhaus der Elisabethinen Linz

    Linz, UPR AUS, 4020, Austria

  • Azienda Ospedaliero Universitaria Pisana

    Pisa, Italy

  • Christian Medical College & Hospital

    Vellore, Tmlnadu, India

  • Clinique Rhône-Durance

    Avignon, Provence, 84082, France

  • Deutsches Herzzentrum München des Freistaates Bayern

    München, Bavaria, 80636, Germany

  • FN U sv. Anny v Brno

    Brno, Moravia-Silesia, 65691, Czechia

  • Haga Ziekenhuis Locatie Leyenburg

    The Hague, South Holland, 2545AA, Netherlands

  • Herzzentrum Dresden GmbH Universitätsklinik

    Dresden, Germany

  • Hospital Clínic de Barcelona

    Barcelona, Catalon, 08036, Spain

  • Hospital General Juan Ramon Jimenez

    Huelva, Andalusia, 21005, Spain

  • Hospital Santa Marta

    Lisbon, Portugal

  • Hospital de Navarra

    Pamplona, Navarre, 31008, Spain

  • Hospital de Santa Cruz

    Carnaxide, Portugal

  • Hospital de São João

    Porto, Porto District, 4202-451, Portugal

  • KH Wiener Neustadt

    Wiener Neustadt, Lower Austria, 2700, Austria

  • Max Super Specialty Hospital

    New Delhi, India

  • Medisch Centrum Leeuwarden

    Leeuwarden, Provincie Friesland, 8934AD, Netherlands

  • Medizinische Einrichtungen der Universität zu Köln

    Cologne, North Rhine-Westphalia, 50937, Germany

  • Ospedale San Raffaele

    Milan, Lombard, 20132, Italy

  • Ospedale dell'Angelo

    Mestre, Veneto, 30174, Italy

  • Pole Sante Republique

    Clermont-Ferrand, Auvergne, 92514, France

  • Policlinico Universitario A. Gemelli

    Roma, Rome, 00144, Italy

  • Polyclinique des Fleurs

    Ollioules, Provence-Alpes-Azur, 83190, France

  • Semmelweis University

    Budapest, Budapest, 1122, Hungary

  • Sree Chitra Tirunal Institute for Medical Sciences & tech.

    Trivandrum, India

  • St. Antonius Ziekenhuis

    Nieuwegein, Utrecht - Canada, 3435CM, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.